These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Heatstroke and hyperthermias. Amore M; Cerisoli M Ital J Neurol Sci; 1992 May; 13(4):337-41. PubMed ID: 1351046 [TBL] [Abstract][Full Text] [Related]
29. Persistent fever in the ICU. Rehman T; deBoisblanc BP Chest; 2014 Jan; 145(1):158-165. PubMed ID: 24394828 [TBL] [Abstract][Full Text] [Related]
30. A prostaglandin theory of neuroleptic malignant syndrome. Yeragani VK; Chaitin P Med Hypotheses; 1987 Oct; 24(2):143-9. PubMed ID: 2891019 [TBL] [Abstract][Full Text] [Related]
31. Management of lethal catatonia with dantrolene sodium. Stemp LI Crit Care Med; 1993 Sep; 21(9):1403. PubMed ID: 8240540 [No Abstract] [Full Text] [Related]
32. [Neuroleptic malignant syndrome]. Schill D Med Monatsschr Pharm; 2005 Oct; 28(10):370-1. PubMed ID: 16247850 [No Abstract] [Full Text] [Related]
34. Functional hyperthermia due to central dopaminergic impairment. Di Rosa AE; Morgante L; Coraci MA; Crisafulli A; Cacciola G; Di Stefano G; Meduri M; Di Perri R Funct Neurol; 1988; 3(2):211-5. PubMed ID: 2900182 [TBL] [Abstract][Full Text] [Related]
35. The treatment and management of neuroleptic malignant syndrome. Gratz SS; Levinson DF; Simpson GM Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):425-43. PubMed ID: 1641490 [TBL] [Abstract][Full Text] [Related]
36. The association between the neuroleptic malignant syndrome and malignant hyperthermia. Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Adnet-Bonte CA; Saulnier F; Dupuis BA Acta Anaesthesiol Scand; 1989 Nov; 33(8):676-80. PubMed ID: 2588999 [TBL] [Abstract][Full Text] [Related]
37. The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity. Balzan MV Postgrad Med J; 1998 Feb; 74(868):72-6. PubMed ID: 9616487 [TBL] [Abstract][Full Text] [Related]